Evaluating Roivant Sciences: Insights From 6 Financial Analysts
Evaluating Roivant Sciences: Insights From 6 Financial Analysts
評估Roivant Sciences：來自6位財務分析師的見解。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $18.33, a high estimate of $23.00, and a low estimate of $15.00. This upward trend is evident, with the current average reflecting a 12.8% increase from the previous average price target of...Roivant Sciences (NASDAQ:ROIV) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
過去三個月，Roivant Sciences (納斯達克：ROIV) 被6位分析師分別看好或看淡。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表提供了分析師最近的評級概述，爲了全面了解過去30天的情緒變化並與前幾個月進行比較，提供了深入的見解。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $18.33, a high estimate of $23.00, and a low estimate of $15.00. This upward trend is evident, with the current average reflecting a 12.8% increase from the previous average price target of...
分析師進行的12個月價格評估揭示了更多細節，其中包括平均目標價18.33美元，最高估價...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間